EU – Pharma GMP

Top OSD GMP Deficiencies Identified in FDA and EU Inspections

digi — Wed, 26 Nov 2025 04:18:04 +0000

Top OSD GMP Deficiencies Identified in FDA and EU Inspections Comprehensive Step-by-Step Guide: GMP Checklist for Oral Solid Dosage Manufacturing Deficiencies Manufacturing oral solid dosage (OSD) forms under current Good Manufacturing Practices (cGMP) demands a rigorous and systematic approach to compliance. Even with well-established pharmaceutical quality systems, regulatory inspections by authorities such as the U.S....

Common BMR Deficiencies Found in FDA and EU GMP Inspections

digi — Tue, 25 Nov 2025 14:51:04 +0000

Common BMR Deficiencies Found in FDA and EU GMP Inspections Step-by-Step Guide to Identifying and Addressing Common BMR Deficiencies in GMP Batch Manufacturing Records (BMRs) are the cornerstone of pharmaceutical manufacturing quality systems. They ensure complete traceability, facilitate compliance with regulatory standards, and support product quality and patient safety. However, observations and deficiencies associated with...

Top QC Laboratory Findings in FDA and EU Inspections

digi — Tue, 25 Nov 2025 14:33:04 +0000

Top QC Laboratory Findings in FDA and EU Inspections Comprehensive Step-by-Step Guide to QC Laboratory Findings and Remediation in FDA and EU Inspections Quality Control (QC) laboratories are critical to ensuring pharmaceutical product quality, safety, and compliance. Regulatory inspections by agencies such as the FDA, EMA, and MHRA identify specific common findings in QC labs...

Top Warehouse GMP Deficiencies Identified in FDA and EU Inspections

digi — Tue, 25 Nov 2025 09:33:04 +0000

Top Warehouse GMP Deficiencies Identified in FDA and EU Inspections Comprehensive Step-by-Step GMP Audit Checklist for Pharmaceutical Warehouse: Addressing Deficiencies from FDA and EU Reports Pharmaceutical warehouses are critical nodes in the supply chain ensuring the integrity, quality, and compliance of medicinal products stored prior to distribution or manufacturing. Regulatory bodies such as the FDA,...

Top OSD GMP Deficiencies Identified in FDA and EU Inspections

digi — Mon, 24 Nov 2025 23:09:42 +0000

Top OSD GMP Deficiencies Identified in FDA and EU Inspections Step-by-Step Guide to Addressing Top OSD GMP Deficiencies Identified by FDA and EU Inspectors Manufacturing oral solid dosage (OSD) forms such as tablets and capsules presents complex challenges under pharmaceutical Good Manufacturing Practice (GMP). Regulatory authorities including the United States Food and Drug Administration (FDA),...

How to Implement an Effective Cross Contamination Control Strategy (EU Annex 1 & 15)

digi — Mon, 24 Nov 2025 20:12:42 +0000

How to Implement an Effective Cross Contamination Control Strategy (EU Annex 1 & 15) Step-by-Step Guide to Implement Effective Cross Contamination Control in Pharmaceutical Manufacturing Cross contamination control is a critical aspect of Good Manufacturing Practice (GMP) in pharmaceutical production. It ensures the safety and quality of pharmaceutical products by preventing the unintentional introduction of...

Batch Manufacturing Record Requirements Under FDA and EU GMP

digi — Mon, 24 Nov 2025 18:21:42 +0000

Batch Manufacturing Record Requirements Under FDA and EU GMP Comprehensive Step-by-Step Guide to Batch Manufacturing Record Requirements Under FDA and EU GMP The batch manufacturing record (BMR) is a critical document within pharmaceutical Good Manufacturing Practice (GMP) frameworks, serving as the definitive record of the production process for each batch or lot of finished product....

Electronic Records and Signatures: Aligning EU Annex 11 and 21 CFR Part 11

digi — Sat, 15 Nov 2025 08:59:47 +0000

Electronic Records and Signatures: Aligning EU Annex 11 and 21 CFR Part 11 Comprehensive Guide to Electronic Records and Signatures Compliance Under EU Annex 11 and 21 CFR Part 11 Pharmaceutical manufacturers and regulatory professionals worldwide face an evolving regulatory landscape concerning the management of electronic records and signatures. Ensuring data integrity and compliance with...

Pharmacy Gmp: How EU and UK Regulators View Pharmacy GMP Compliance

digi — Fri, 14 Nov 2025 17:41:47 +0000

Pharmacy GMP Compliance: Insights on US and UK Regulatory Perspectives Step-by-Step Guide to Understanding How US and UK Regulators View Pharmacy GMP Compliance The pharmaceutical manufacturing environment, especially within hospital and community pharmacy settings, requires strict adherence to Good Manufacturing Practice (GMP) to assure medication quality and patient safety. This tutorial provides a detailed step-by-step...

Unified Pharma GMP Guidelines: Integrating US, EU, and ISO Standards

digi — Fri, 14 Nov 2025 14:26:47 +0000

Pharma GMP Guidelines: Integrating US and ISO Standards into One Unified Framework Step-by-Step Guide to Implementing US and ISO GMP Standards in One Cohesive Framework Pharmaceutical manufacturing demands strict adherence to Good Manufacturing Practice (GMP) guidelines to ensure product quality, patient safety, and regulatory compliance. This tutorial presents a detailed, step-by-step guide designed for pharmaceutical...